
|Articles|February 15, 2005
Surgery: consider before adding another medication?
New Orleans—Adding a third or fourth medication to a glaucoma patient's therapeutic regimen has many drawbacks but a few potentially positive aspects as well and should be considered on an individual patient basis, said Shan C. Lin, MD, assistant professor of clinical ophthalmology, University of California, San Francisco, and San Francisco General Hospital.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
Noninvasive LED light therapy shows long-term safety in early cataract clinical follow-up
3
IGS 2026: The expanding role of artificial intelligence in ophthalmology
4
The Residency Report: PreserFlo microshunt vs trabeculectomy—five-year trial insights
5




























